The hormonal and humoral regulators of myocardial protein metabolism : the in vivo measurement of the physiologic role of insulin and amino acids in cardiac protein kinetics by Dahl, Douglas Middleton
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
1992
The hormonal and humoral regulators of
myocardial protein metabolism : the in vivo
measurement of the physiologic role of insulin and
amino acids in cardiac protein kinetics
Douglas Middleton Dahl
Yale University
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Dahl, Douglas Middleton, "The hormonal and humoral regulators of myocardial protein metabolism : the in vivo measurement of the
physiologic role of insulin and amino acids in cardiac protein kinetics" (1992). Yale Medicine Thesis Digital Library. 2504.
http://elischolar.library.yale.edu/ymtdl/2504
Ripiiii 
• r't 
;;:'- 
. V -r-/.:•■; :■ :V- ■ 
■ ■■ '•■ 
V" " I $ - 
IN VIVO ANABOLIC EFFECT OF INSULIN 
AND AMINO ACIDS ON THE CANINE 
HEART 
DOUGLAS MIDDLETON DAHL 
1992 
l:h ■■■■...r.-'.-'■% 
... ■ V; IV-ZiivfPfi ■■' - •*'-V"KV "' ' C'V-{>:>>' :<?/••; •-!-• 
.■: • V' /'. y:.;: ■ ;S - 
■ :■ : "jO ■ r-t/5;\" ‘1 ' / 
YALE 
MEDICAL LIBRARY 
Permission for photocoping or microfilming of "_ 
vWo ic Th £ 
(Title of thesis) cJK,07A)& \4^ 
for the purpose of individual scholarly consultation or reference 
is hereby granted by the author. This permission is not to be 
interpreted as affecting publication of this work or otherwise 
placing it in the public domain, and the author reserves all rights 
of ownership guaranteed under common law protection of unpublished 
manuscripts. 
V 
Date 
Digitized by the Internet Archive 
in 2017 with funding from 
The National Endowment for the Humanities and the Arcadia Fund 
https://archive.org/details/hormonalhumoralrOOdahl 


The Hormonal and Humoral Regulators of Myocardial Protein 
Metabolism: 
the in vivo measurement of the physiologic role of insulin and 
amino acids in cardiac protein kinetics 
Douglas Middleton Dahl 
A thesis in partial fulfillment of the requirements for the degree 
Doctor of Medicine 
Yale University School of Medicine 
Department of Internal Medicine 
1992 
(vw=>c\ Ub 
n i J 
Dedication 
To my parents, Mary Middleton Dahl, M.D. and Douglas 
Seely Dahl, M.D., with enormous gratitude for their 
support, encouragement, and inspiring example. 

I 
Introduction 
IN VIVO ANABOLIC EFFECT OF INSULIN AND AMINO ACIDS ON THE 
CANINE HEART. Douglas M. Dahl, Eugene J. Barrett, and Lawrence 
H. Young. Section of Cardiology, Department of Internal Medicine, 
Yale University School of Medicine, New Haven, CT. 1992. 
Though it has been studied extensively in vitro, the 
physiologic role of insulin in regulating protein metabolism in the 
heart in vivo has not previously been determined. Using 
radioactively-iabeled phenylalanine as a tracer molecule, we 
measured rates of protein synthesis and degradation in fasted, 
anesthetized dogs before and during a hyperinsulinemic 
(2mU/kg/min) euglycemic clamp, during a clamp and infusion of 
an amino acid solution, or during infusion with saline alone. We 
measured the uptake of radioactively-iabeled phenylalanine from 
plasma and the release of unlabeled phenylalanine by cardiac 
muscle using arterial and coronary sinus catheterization during a 
continuous infusion of radioactive L-[ring-2,6-3H] phenylalanine. 
After both a 16 hour (n=19) and a 36-hour fast (n=10), the heart 
was in net negative phenylalanine balance (-52±9 nmol/min, 
p<0.001; and -38±9, p<0.005 respectively), and those animals 
fasted 36 hours had a lower rate of protein degradation (81 ±13 
vs. 121 ±12 nmol/min, p<0.05). Phenylalanine balance and rates of 
protein synthesis and degradation did not change in group I (n=10, 
fasted 36 hours) which received the hyperinsulinemic euglycemic 
clamp. In these animals, insulin produced a 30-40% decline in 
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plasma amino acid concentrations including branched chain 
(p<0.001) and essential amino acids (p<0.001). Group II (n=11, 
fasted overnight) received amino acid supplementation with the 
clamp. In these animals, myocardial phenylalanine balance 
changed from negative (-40±6 nmol/min) to neutral (6±7, p<0.05) 
because of an inhibition of heart protein degradation (118±12 vs. 
60±7 nmol/min, p<0.001), with no change in rates of protein 
synthesis. Group III animals (n=8, fasted overnight) showed 
negative net phenylalanine balance which remained unchanged 
throughout the saline infusion. Hyperinsulinemia has a relative 
anabolic effect on the heart by inhibiting protein degradation. 
Hypoaminoacidemia blunts insulin's effect as an anabolic 
hormone. 
We provide the first evidence in vivo that physiologic 
increments of plasma insulin have an important role in regulating 
myocardial protein turnover. Hyperinsulinemia appears to inhibit 
proteolysis of heart protein and has no effect of stimulating 
protein synthesis. The anti-proteolytic effect of insulin, 
however, is blunted by hypoaminoacidemia. The non-destructive 
method of measuring cardiac protein synthesis and degradation 
used in these large animal experiments offers the possibility of 
studying protein metabolism in humans and its response to a 
variety of interventions and disease states. 
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Background 
Understanding the normal and pathologic growth of the heart 
is an important goal for physicians hoping to combat heart 
disease. When increased demands are placed on it, the heart 
adapts by growing in bulk. At first, the hypertrophied heart 
delivers greater power to meet the needs of the animal, but 
ultimately the enlarged heart fails as a pump. The process which 
initially improves the health of the organism eventually leaves it 
greatly weakened. This scenario is common in heart disease in 
humans. Disorders of the heart valves and hypertension are both 
common conditions in man which demand that the heart work 
harder to deliver blood. After a period which may last decades in 
which the enlargement of the heart restores hemodynamic 
equilibrium, the heart decompensates with often fatal 
consequences for the patient. This explains why the growth of the 
heart has been the focus of scientific study for over one hundred 
years (Zak, 1984). 
The Importance of Understanding Myocardial Protein 
Kinetics 
The heart is a muscular organ whose main function is to 
circulate blood throughout the body. As in other muscle tissues, 
the heart produces work through the coordinated contraction of 
millions of cells, each of which contains an elaborate contractile 
apparatus. The intracellular machinery for producing these 
carefully regulated contractions is composed largely of proteins. 
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Membrane channels, signal transduction proteins, and enzymes for 
cellular respiration support and regulate the function of the 
structural myofibrillar elements including actin and myosin. 
Taken together, protein comprises approximately 16% of the wet 
weight of muscle tissue. 
Tissue protein undergoes continual turnover (Cahill, 1976). 
The cell degrades older proteins and replaces them with newly 
synthesized molecules. Because breakdown and synthesis occur 
simultaneously in each cell, the net flux of protein is considerably 
smaller than the individual rates for accumulation and 
degradation. Complex signals both within the cell and from 
outside it control the rates of these synthetic and degradative 
processes, so that depending upon these signals there may be net 
increase or decrease in total cellular protein. Thus the cell 
grows, remains at a constant mass, or atrophies in response to a 
large number of variations in nutritional supplies, hormonal 
signals, and work load. 
Muscle serves two important functions for the organism. 
First, it has an obvious mechanical function in producing mobility 
of body and limbs. Second, as the body's largest reservoir of 
protein, it serves as a vital storehouse of nitrogen and carbon 
skeletons - in the form of amino acids - which are essential to 
support the normal growth and repair of other tissues, in times of 
nutritional deprivation or stress, the body also mobilizes these 
stores for use by the liver and kidneys as gluconeogenic 
substrates. in prolonged starvation, the body will sacrifice the 
strength of the muscle tissues in favor of providing metabolic 
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energy for the whole organism. In the long term - usually about 7 
days in humans - the body adapts to nutritional deprivation so that 
muscle is relied upon less as a source of metabolic energy 
(Saudek, Vignati). The cost of this to the organism, however, is 
reduced functional capacity of the muscle tissue. Reduction of 
body protein by 8 to 17 percent in healthy people has been shown 
to compromise fitness. This amount of loss is commonly seen in 
critically ill hospital patients who often have accelerated 
catabolism and are unable to maintain adequate nutrition 
(reviewed in Wilmore, 1991). 
It is well known that cardiac muscle hypertrophies and 
atrophies in response to functional demands placed on it. The 
transition seen in the heart at the time of birth nicely illustrates 
both phenomena. In the fetal heart, the right ventricle performs 
the bulk of the work of circulating blood. When the child breathes 
its first breaths, the right ventricle assumes a new role in 
providing volume at much reduced pressures to the newly low 
resistance pulmonary vascular bed. Concomitantly, the post¬ 
partum left ventricle must produce high pressures for the first 
time to meet the demands of the systemic circulation. The heart 
responds to this change in functional demands with rapid growth 
of the left ventricle and relative atrophy of the right ventricle. 
Experimental evidence has shown that this remodeling is 
associated with an accelerated rate of protein synthesis in the 
left ventricle which persists only until the size of the chamber is 
sufficiently large to accommodate its new workload efficiently 
(Robinson, 1990). In adults, pathologic hypertrophy of the left 
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ventricle is seen in people with stenotic or regurgitant valvular 
lesions and in systemic hypertension. Each of these conditions 
results in hypertrophy of the myocardium in response to increased 
work load to deliver the same volume of blood. 
Controversy exists in the heart's role as a protein reservoir 
for the rest of the body. The heart’s pumping function is so 
central to the survival of the organism that any functional 
compromise resulting from breakdown of its protein constituents 
could be very deleterious to the animal. The classical teaching 
was that "inanition has no harmful effect on the heart" (Vasquez, 
1924). Several lines of evidence indicate that the heart responds 
differently than skeletal muscle to humoral signals which 
influence the rates of protein synthesis and breakdown, but the 
distinction is not consistent in all experiments (reviewed in 
Sugden, 1991). Review of studies of malnutrition in humans 
shows that myocardial skeletal muscle mass decline 
proportionally with resultant impairment in the heart's ability to 
generate cardiac output (Webb, 1986). The understanding of the 
regulation of heart growth has been impeded by the complexity of 
measuring the rates of protein synthesis and degradation in the 
heart in vivo. Diverse techniques have yielded sometimes 
conflicting evidence as discussed below. 
Experimental Approaches to Quantifying Protein 
Synthesis 
Investigators have used a variety of experimental methods 
to measure the rates of protein synthesis and degradation, and the 
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response of tissues to experimental interventions (reviewed in 
Waterlow 1978). Most methods employed to estimate the rate of 
protein synthesis, both in vitro and in vivo, involve measuring the 
incorporation of radioactively labeled amino acids into cellular 
protein during a specified time interval. The tracer molecules are 
administered as either a continuous infusion or with a flooding 
bolus (reviewed in Sugden, 1991). With this technique, the rates 
of synthesis in whole tissues or of individual proteins can be 
assayed. The expression of individual genes coding for specific 
proteins can also be measured through in vitro translation of 
mRNA isolated from the tissues under study (Dillman, 1983). 
The accuracy of measurements of tissue protein synthesis 
which use labeled amino acid molecules rests on four 
assumptions. First, the specific activity of labeled amino acid in 
the measurable medium, e.g plasma, must be equivalent or have a 
known relationship to that of the immediate precursor pool within 
the tissue, the amino-acyl tRNA in the case of protein synthesis. 
Because proteins are continually turning over, the specific 
activity in the medium may be higher than that within the 
cytoplasm of the cell as that precursor pool is diluted by 
unlabeled amino acid from protein breakdown. This would 
potentially result in an underestimation of the protein synthetic 
rate using plasma specific activity. Second, any breakdown of 
proteins which contain labeled amino acid will also result in an 
underestimate of the synthetic rate. Third, the labeled amino acid 
must not undergo cellular loss of radioisotopic tracer which 
would alter the relationship between plasma and tRNA specific 
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activity. Fourth, the labeled amino acid itself must not behave 
differently, i.e. have lower affinity for cellular enzymes, than the 
native molecule. 
The ideal amino acid tracer is one which rapidly equilibrates 
with the precursor pool and is not metabolized by the target 
tissue. Radioactively labeled phenylalanine, leucine, and tyrosine 
in culture medium each begin to be incorporated at linear rates 
into muscle protein (Morgan 1971, Jefferson 1977, Clark 1981). 
These amino acids are all transported with high activity by the L- 
system neutral amino acid transporter which transports branched 
chain and aromatic amino acids, but does not generate a 
transmembrane gradient of these molecules or maintain a large 
intracellular store (Banos 1973, Banos 1978, Morgan 1971, Cahill 
1972, Waterlow 1978). Before incorporation into protein, amino 
acids are activated by acylation to tRNA. In tracer studies both in 
vitro and in vivo, comparison of the specific activity of total 
cellular amino acid with amino-acyl tRNA has demonstrated that 
the specific activity of the total cellular pool is lower (McKee 
1978, Martin 1977, Everett 1981). This difference raises 
questions about the reliability of estimates which rely upon the 
assumption that exogenously introduced labeled amino acids 
freely equilibrate with all cellular amino acid pools. Fortunately, 
several studies have shown that extracellular specific activity 
closely reflects that of the cellular tRNA. In vivo studies 
administering a bolus of labeled leucine intravenously showed 
that plasma and leucyl-tRNA specific activities were nearly 
identical and that the equilibration was very rapid (<5 min.) 
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(Martin 1977, Everett 1981). Labeled phenylalanine at physiologic 
concentrations perfused into an isolated heart preparation showed 
that the specific activity of the medium and the phenylalanyl- 
tRNA were within 20% (McKee 1978). During continuous infusion 
in vivo, labeled phenylalanine has been demonstrated to 
equilibrate very rapidly between plasma and tissue tRNA 
precursor pools (Revkin, 1990). Thus in heart, measurements of 
labeled phenylalanine in plasma can be confidently used to 
estimate the specific activity of the immediate precursor pool to 
protein synthesis. 
Measurement of Protein Degradation 
Protein degradation has been much more difficult to assess 
and no method has gained acceptance as a reliable measure 
(reviewed in Barrett 1989). Indirectly, the rate of protein 
breakdown is often inferred from the difference between the 
measured rate of protein synthesis and the change in mass of the 
tissue over a given interval. While each of the two measurements 
is reliable, their combination is problematic. Synthetic rates 
measured by isotope incorporation are accurate when the 
experimental time course is minutes to a few hours. After that, 
the error introduced by recycling of amino acids, and variations in 
the hormonal milieu becomes more significant. Changes in the 
mass of muscle protein are only accurately determined over the 
course of days during which time the rate of protein synthesis 
may have fluctuated significantly. Combining these two 

measurements compounds the potential error in a value 
determined for protein degradation (Barrett, 1989). 
The drug cyclohexamide is a powerful inhibitor of ribosomal 
translation of mRNA into protein. In an experimental system in 
which protein synthesis is blocked pharmacologically, amino acid 
release measured by dilution of tracer specific activity should 
provide a valid measure of protein breakdown. Myocardial protein 
degradation theoretically may be determined by measurement of 
the arteriovenous difference in amino acid concentration across 
the heart after administration of cyclohexamide. One drawback, 
however, is that cyclohexamide is a potent toxin and its full 
effect on tissues is unknown and may influence the process of 
protein degradation itself (Goldberg 1974). Another limitation is 
that it obviously cannot be used in human investigation. 
The measurement of 3-methylhistidine release by the heart 
might theoretically also allow a direct assay of protein 
breakdown. Formed by methylation of histidine residues bound in 
actin (Asatoor 1967) and in some forms of myosin, 3- 
methylhistidine is not reutilized for protein synthesis once it has 
been released in the degradative process (Young, VR 1970). The 
arteriovenous difference in 3-methylhistidine across skeletal 
muscle beds is so small as to preclude anything but a 
semiquantitative measure of myofibrillar protein breakdown 
(Barrett 1989). With a blood flow rate per gram of tissue 
approximately twenty times that of skeletal muscle and a lower 
3-methylhistidine content, cardiac muscle will! produce a 

significantly lower arteriovenous gradient and therefore be even 
more difficult to study precisely. 
A Novel Approach to Quantifying Protein Turnover 
One of the greatest limitations to understanding the normal 
physiology of myocardial growth is that direct tissue sampling is 
required for most methods described above. Whether in atrial 
tissue in vitro (Cohen, 1969), in the isolated, perfused heart 
(Chua, 1979; Smith, 1983), or in sacrificed experimental animals 
(Samarel, 1987; Preedy, 1989), the rates of protein synthesis and 
degradation and the effects of experimental interventions are 
determined by methods which require tissue analysis. To study 
the heart in vivo by these techniques would require an open-chest 
model. The extensive surgical preparation required for such 
studies would add a confounding factor in extrapolating results to 
the truly physiologic state. Furthermore, they would necessitate 
that large tissue samples be taken from the heart. This would 
have limited applicability in studying the effects before and after 
interventions within the same animal, and obviously could not be 
used in man. 
A novel method for simultaneously directly assessing both 
protein synthesis and protein degradation in vivo using 
isotopically-labeled amino acids was developed in this laboratory 
(Barrett, 1987; Revkin, 1990; see methods). Because 
phenylalanine's only metabolic fate in muscle tissue is 
incorporation into protein (Williams, 1981) and it is a well- 
represented amino acid in heart muscle protein (Morgan, 1971), it 

can serve as a useful estimator of heart protein kinetics. By 
measuring the flux of phenylalanine in and out of heart muscle, we 
can estimate the kinetics of total protein turnover. We measured 
the dilution of specific activity and the balance of radioactively 
labeled phenylalanine across the heart in vivo. This technique 
affords a nondestructive method of investigating the effects of a 
variety of experimental interventions and allowed us to examine 
the physiologic role of insulin and amino acids in the regulation of 
myocardial protein synthesis. 
Factors Influencing Myocardial Protein Metabolism 
A wide variety of investigations into the regulation of heart 
protein synthesis and degradation have been performed. Many have 
examined the effects of starvation on protein synthesis and 
degradation (Curfman, 1980; Crie, 1980; Preedy, 1984; Samarel, 
1987). In animal models, the influence of anoxia and ischemia 
(Kao, 1976; Chua, 1979; Smith, 1983; Preedy, 1989), pressure 
overload (reviewed in Zak, 1984 and Barrett, 1989), and 
circulating concentrations of various amino acids (reviewed in 
Sugden, 1991) have been extensively examined because of their 
obvious clinical relevance. Though patterns have emerged, the 
results are inconsistent and often contradictory due to the myriad 
technical considerations outlined above. 
Since its discovery in 1922 (Banting, 1922), insulin's role as 
a hormone signalling the plenitude of nutrients to tissues has been 
copiously studied. Many experiments investigating insulin's role 
in cardiac protein metabolism have again left a complex set of 

findings. In the isolated perfused heart, insulin has repeatedly 
been shown to stimulate protein synthesis (Morgan, 1971; Rannels, 
1975; Preedy, 1984). In diabetic animals in vivo, heart protein 
synthesis is diminished in comparison with normals. Insulin has 
been demonstrated to restore the synthetic rate toward that seen 
in control animals (Pain, 1974; Ashford, 1986), but showed no 
stimulatory effect in nondiabetic animals. In another study, 
glucose infusion in young, growing rats (with its resultant 
hyperinsulinemia) did stimulate heart protein synthesis (Garlick, 
1988). The degradative rate of protein in the isolated heart is 
reduced by high levels of insulin (Rannels, 1975; Curfman, 1980). 
A similar effect has been demonstrated in diabetic rats in vivo 
(Ashford, 1986). 
The Current Study 
Throughout the day in the normal animal, periods of fasting 
alternate with periods of eating. Following a meal, insulin is 
released and circulates in plasma at high levels, signaling to 
diverse tissues throughout the body that nutrients are plentiful. 
Between meals, the concentration of insulin is markedly 
diminished, but always present in measurable amounts. Studies of 
insulin's influence on cardiac protein metabolism carried out in 
myocardial tissue in vitro or in isolated perfused hearts have 
yielded valuable data, but the results are difficult to extrapolate 
to the situation in vivo. Furthermore, as discussed above, 
degradative rates of cardiac protein have been particularly 
difficult to determine and therefore not addressed by many 

studies which measure rates of protein synthesis. Recent data 
suggest that insulin's most prominent role in regulating protein 
metabolism is to inhibit proteolysis. This is true in human 
skeletal muscle in which insulin has no effect on skeletal muscle 
protein synthesis but does block proteolysis (Gelfand, 1987; 
Fryburg, 1990). Studies in the normal adult rat have shown that 
insulin does not have the effect of increasing heart protein 
synthesis (Ashford, 1986), thus it appeared particularly important 
that the influence of insulin on the heart's rate of protein 
degradation be more thoroughly addressed. 
We sought to define insulin's effect on protein metabolism 
in a physiologic experimental system. Utilizing the 
nondestructive isotopic method for simultaneously measuring 
protein synthesis and degradation (Barrett, 1987; Revkin, 1990), 
we undertook the study of the effects of fasting and physiologic 
hyperinsulinemia, both with and without amino acid replacement, 
on the protein kinetics of the canine heart. 

Experimental Methods 
Animal preparation 
Twenty-nine adult mongrel dogs, each weighing 20 to 25 
kilograms, were fasted either overnight (18 hours) or for 36 hours 
before the beginning of the study. Anesthesia was induced with 
intravenous sodium pentobarbital (20 mg/kg) and maintained with 
either sodium pentobarbital or intravenous alpha chloralose 
urethane. The animals were intubated and ventilated with room 
air. An electrocardiogram was monitored continuously and 
arterial blood gas measurements were made at regular intervals 
throughout the experimental protocol. Arterial and coronary 
venous blood was sampled from catheters in the right femoral 
artery and coronary sinus. Arterial blood was sampled and blood 
pressure monitored through a 7 French arterial catheter. Arterial 
blood pressure was measured with a pressure transducer (P23XL, 
Spectramed, Inc., Oxnard, CA) and recorded by a multi-channel 
strip chart recorder (Gould Inc., Cleveland, OH). Under 
fluoroscopic guidance, two catheters were placed into the mid 
coronary sinus. One 6 French multipurpose catheter was placed 
for blood sampling. A second catheter, a 7 French Bairn 
thermodilution flow catheter (Electrocatheter Co., Rahway, N.J.) 
was inserted into the mid coronary sinus to measure coronary 
venous flow rates by the thermodilution method (Ganz 1971, 
Pepine 1978). Position of the coronary sinus catheters was 
verified to be sufficiently distal in the coronary sinus to avoid 
admixture of coronary sinus and right atrial blood which occurs 

with more proximal placement. The coronary sinus catheters were 
secured before the first sampling period and their positions 
reconfirmed by fluoroscopy at the conclusion of the experiment. 
The patency of all catheters was maintained with intermittent 
flushes of heparinized saline (Heparin 500 U/L in 0.9% saline). 
Infusion Protocols 
For 60 to 90 minutes prior to the initial blood sampling, 
each animal received a continuous infusion of L-[ring-2,6-3H]- 
phenylalanine (0.75 mCi/min) (Amersham Corp., Arlington Heights, 
IL) via a hindlimb vein. After this tracer equilibration period, 
basal arterial and coronary sinus blood was sampled four times, 
and three coronary sinus flow measurements made during a 15- 
minute period. Following baseline sampling, a primed (4 
mU/kg/min for 10 minutes) continuous (2 mU/kg/min) infusion of 
regular porcine insulin (Eli Lilly Corp., Indianapolis, IN) was begun. 
Blood glucose was maintained at baseline levels by adjusting the 
rate of intravenous infusion of 20% dextrose according to the 
hyperinsulinemic euglycemic clamp technique (DeFronzo 1979). 
We undertook three distinct experiments: 
Group I - fasted 36 hours, received hyperinsulinemic 
euglycemic clamp alone for two hours. 
Group II - fasted overnight, received hyperinsulinemic 
euglycemic clamp for two and a half hours and supplement with 
amino acid infusion. 
Group III - fasted overnight, received two hour saline 
infusion alone. 

Ten animals fasted for 36 hours underwent a two-hour 
euglycemic clamp. In the animals that received supplemental 
amino acids (n=11, overnight fasted), the clamp time was 
extended to two and a half hours to assure steady state plasma 
levels of the amino acids. The amino acids were given as a 
continuous infusion of a balanced solution (Travasol™, Clintec 
Nutrition Co., Deerfield, IL) to prevent the hypoaminoacidemia 
associated with insulin infusion (Schwartz, Fukagawa). The 
infusion of 1.2 mg/kg/min of Travasol™ delivered 6.2 x IQ'2 
mg/kg/min of unlabeled phenylalanine which maintained the 
plasma concentration of phenylalanine at approximately the 
baseline levels. An additional group of eight animals fasted 
overnight received infusions only of saline and labeled 
phenylalanine as above. During the last 15 minutes of each of 
these three infusion protocols, arterial and coronary blood 
samples were again drawn in quadruplicate and coronary sinus 
flow measurements by thermodilution were made in duplicate. 
Analytic Measurements 
The concentration of glucose in whole blood was measured 
using the glucose oxidase method (Yellow Springs Instruments, 
Yellow Springs, OH). Blood was collected in heparinized tubes and 
centrifuged for 10 minutes. The plasma was separated from each 
blood sample and diluted 1:1 with 6% sulphosalicylic acid to 
precipitate protein, centrifuged for 30 minutes, and aliquots of 
the acid extracts were taken to assay concentrations of neutral 
and acidic amino acids by an automated ion-exchange 

chromatographic technique (Dionex D-500, Sunnyvale, CA) (Barrett 
1987). 
High performance liquid chromatography (HPLC) was used to 
measure phenylalanine concentrations more precisely. A second 
portion of supernatant (2ml) was passed over a Dowex 50W ion 
exchange column (Biorad Laboratories, Richmond, CA) which 
retains amino acids but not their oxo derivatives. Amino acids 
were eluted with 1m NH4OH. The eluant was dried and 
reconstituted with 2% trichloroacetic acid. Next, 0.2 ml of this 
solution (equivalent to 0.5 ml of plasma) was applied to a 
reverse-phase HPLC column (Ultrasphere ODS [C-18, 5mm], 
Beckman Instruments, Inc., Fullerton, CA) and eluted isocratically 
with a mobile phase consisting of 16% methanol (vol/vol) 
containing a phosphoric acid buffer and heptane sulfonic acid as an 
ion pairing agent (Low UV-PIC B7, Waters Associates, Milford, 
Mass.). The column eluant was monitored for ultraviolet 
absorbance at 214 nm, and a sharply separated phenylalanine peak 
was eluted at 14-16 minutes. This fraction was collected in 
scintillation vials and counted for 3H radioactivity by a liquid 
scintillation system (Packard Instruments, Downers Grove, III.). 
The mass of phenylalanine in each sample was calculated by 
comparing its peak area with that of prepared standards using a 
chromatography software package (Nelson Analytical, Cupertino, 
CA). Specific activity is calculated as the 3H radioactivity 
divided by the mass of phenylalanine. 
In control experiments (Barrett, 1987), recovery of labeled 
phenylalanine from the Dowex column was greater than 95%. 

Using the above HPLC method, the coefficient of variation of 
phenylalanine concentration was ±1.9%, ±1.4% for measurements 
of radioactivity, and ±2.2% for specific activity (Revkin, 1990). 
At the end of a three-hour infusion of labeled phenylalanine in the 
dog, more than 95% of the 3H in plasma amino acids is present in 
phenylalanine and less than 1% is in its metabolic product 
tyrosine (Barrett, 1987). 
Calculations 
Rates of protein synthesis and degradation were determined 
by measurements of the kinetics of labeled phenylalanine in the 
heart. The derivation of the formulae used to estimate these rates 
begins with the equation which estimates protein degradation 
from dilution of plasma phenylalanine specific activity (SA): 
Degradation = [Phe]arteriai x {(SAart/SAcs) - 1} x flow (1) 
where [Phe] is the concentration of phenylalanine in arterial 
plasma, SA is the phenylalanine specific activity in arterial and 
coronary sinus plasma, and flow is the coronary sinus blood flow 
measured by thermodilution. This gives the rate of phenylalanine 
release from heart muscle protein in nmol/min. 
Labeled amino acid is also extracted by myocardial tissue. 
The extraction ratio is given by the expression: 
ER = (DPMart - DPMCS) / DPMart (2) 
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where DPM is radioactive disintegrations per minute of labeled 
phenylalanine per milliliter of plasma. 
Phenylalanine is neither synthesized nor metabolized by the 
heart. The difference between its rate of incorporation into 
protein and its rate of release by degradation of protein therefore 
defines its net balance across the heart: 
phenylalanine balance = synthesis - degradation (3) 
where these values are expressed in nanomoles of phenylalanine 
per minute. The balance is determined directly by the 
measurements of the amino acid concentration and rate of flow 
across the heart: 
balance = ([Phe]art - [Phe]cs) x flowcs (4) 
By algebraically rearranging equations 4 and 1 and 
incorporating them into equation 3, a solution emerges by which 
protein synthesis can be determined directly: 
synthesis = {(DPMart - DPMCS)/ SAcs}*flow (5) 
The rates of incorporation and release of phenylalanine are 
converted to rates of tissue protein synthesis and degradation by 
correcting for the measured molar representation of phenylalanine 
in myocardial protein (290 nmol/mg). 
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*A Note on Authorship 
*(!n compliance with the recommendation of the Thesis 
Subcommittee of the Educational Policy and Curriculum 
Committee.) 
The animal preparation and experimentation is a complex 
undertaking requiring the contribution of several workers. For the 
insulin and the insulin plus amino acids groups, Lawrence Young 
M.D., Eugene Barrett M.D. Ph.D., and I performed the bulk of the 
work. On several occasions I have performed each of the 
procedures described in "animal preparation" and "infusion 
protocols", including preparing the infusion solutions, performing 
the surgical cutdowns and placement of the arterial and venous 
catheters, and performing the euglycemic clamp. We were 
assisted by Jon Alderman, George Harnish, and Jill Seres. For the 
insulin alone group and approximately half of the insulin plus 
amino acids group, I performed all the separations and chemical 
analyses described in "analytic measurements" with the 
exceptions below. For all experiments, Ralph Jacob, Ph.D. ran the 
automated amino acid analyzer and Rosa Plendler M.D. measured 
insulin concentration by radioimmunoassay. Deborah Rauner 
processed the blood samples for half the insulin plus amino acids 
group and the entire saline infusion group. 
This work was supported by grants from the Yale summer 
fellowship, USPHS K08 HL 01840, AHA 870328, and Clintec 
International, Deerfield, Illinois. 
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Results 
Metabolic effects of the euglycemic clamps. 
Animals undergoing the euglycemic clamp should 
demonstrate evidence of the effects of insulin, including 
increased glucose disposal, while maintaining their plasma 
glucose concentration. In the animals fasted 36 hours, insulin 
infusion without amino acid replacement increased plasma insulin 
from 9±1 to 106+9 mU/ml (p<0.001). This hyperinsulinemia 
resulted in a whole body glucose utilization of 8.0±0.6 mg/kg/min 
and increased myocardial glucose uptake more than doubled (2.2- 
fold increase, p<0.005) (Table I). Whole blood glucose was 
maintained constant at basal levels (63±2 mg/dl) during insulin 
infusion without amino acid replacement. 
Though the basal blood glucose concentrations in the animals 
fasted overnight that received the euglycemic clamp and amino 
acid infusion were significantly higher than in the 36-hour fasted 
animals (70±2 vs. 63±2, p<0.01), they had similarly low basal 
plasma insulin concentrations (9±1 mU/ml) and myocardial 
glucose disposal (2.6±0.8 and 3.1±0.6 respectively, p=not sig.). 
The overnight-fasted group receiving both insulin and amino acids 
responded with a whole body glucose disposal (8.7±0.8 mg/kg/min) 
and increased myocardial uptake (2.2-fold increase, p<0.001) not 
significantly different than the 36-hour fasted group at the 
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Table I: Arterial Glucose and Insulin. Whole Body and 
Heart Glucose Uptake 
Blood 
Glucose 
(mg/dl) 
Plasma Myocardial 
Insulin M Glucose Uptake 
(pU/ml) (mg/kg/min) (mg/min) 
Euglycemic Clamp 
(36-hour fast) 
Basal 63±2 9±1 3.1±0.6 
Insulin 65±1 106±9* 8.0±0.6 6.8±0.9t 
Euglycemic Clamp + Amino Acids 
(Overnight fast) 
Basal 70±2¥ 9±1 2.6±0.8 
Insulin 71 ±2§ 106±14* 8.7±0.8 5.7±0.9* 
Saline Infusion 
(Overnight fast) 
Basal 66±2 10±1 
Saline 65±3 7±1 
2.6±0.6 
2.6±0.6 
Data are mean values ± Standard Error of the Mean for 
the arterial concentrations of glucose and insulin and for 
myocardial glucose uptake during the basal period (Basal) 
and the last 15 minutes of the infusion protocols (Insulin or 
Saline). M is the mean whole body glucose utilization rate 
during the euglycemic clamps (see Methods). *p < 0.001 and 
tp < 0.005 compared to basal value determined by paired t 
test; ¥p < 0.01, §p < 0.05 compared to Euglycemic clamp by 
unpaired t test. 
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same circulating insulin concentration (106±14mU/ml) (Table I). 
In the group of animals fasted overnight that received saline 
infusion alone, the baseline whole blood glucose, plasma insulin, 
and myocardial glucose utilization were similar to the overnight- 
fasted animals that received insulin and amino acid infusions. In 
the saline control group, these characteristics did not change 
during the course of the saline infusion (Table I). 
Hemodynamics and Coronary Blood Flow 
Heart rate, blood pressure, and coronary sinus blood flow 
were monitored throughout each experiment. Coronary sinus blood 
flow was similar in all three groups and did not change during the 
course of the experiments (Table II). At baseline, animals fasted 
36 hours had slightly higher baseline heart rates and significantly 
greater mean arterial blood pressures than animals fasted 
overnight (p<0.02). All groups had consistent hemodynamic 
parameters except the insulin plus amino acid group which 
experienced a modest, but statistically significant 13% rise in 
arterial blood pressure during the course of the experiment 
(p<0.02 for systolic BP, p<0.05 for mean arterial pressure) (Table 
II). 
Effects of Infusions on Amino Acid Concentrations 
Concentrations of plasma amino acids were measured in 
quadruplicate plasma samples at baseline and again during the 
last 20 minutes of each infusion. Data are from an automated 
amino acid analyzer (see Methods). The mean values of individual 
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Table II: Hemodynamics and Coronary Blood Flow 
Double Coronary 
Heart Rate Systolic BP Mean BP Product Blood 
Flow 
(min'1) (mm Hg) (mm Hg) (mmHg/min*1 0'3) (ml/min) 
Euglycemic Clamp 
Basal 159±9 1 65±4 1 46±6 25.7±2.2 57±4 
Insulin 1 54±11 
Euglycemic Clamp + 
1 67±3 
Amino Acids 
149±5 25.3±2.2 58±6 
Basal 142±9 1 39±9 11 3±6 20.0±2.2 60±9 
Insulin 1 39±7 157±5* 128±4t 22.1 ±1.7 63±9 
Saline 
Basal 138±16 165±9 1 37±7 23.0±3.2 62±8 
Saline 1 59±11 1 73±5 146±2 27.7±2.3 64±9 
Data are mean ± Standard Error of the Mean of quadruplicate 
values measured prior to (Basal) and during the last 15 
minutes of the infusion protocols (Insulin or Saline), *p < 
0.02 and tp < 0.05 compared to basal by paired t test. 

26 
amino acids from quadruplicate samples in each experimental 
group are shown in Table III. Figure 1 displays graphically the 
summed values for branched chain, essential, and total amino 
acids. 
In the group of animals fasted 36 hours that received insulin 
alone, concentrations of nearly all amino acids measured - non- 
basic amino acids - decreased substantially (Table 111). Infusion 
of insulin significantly reduced the concentrations of the 
essential amino acids threonine and valine (p<0.02 for each), and 
methionine, isoleucine, leucine, tyrosine, and phenylalanine 
(p<0.001 for each) (Table III). Overall, the measured essential 
amino acids decreased 37% during the euglycemic clamp. The 
total amino acid concentration fell 34% and the concentration of 
the branched-chain amino acids (leucine, isoleucine, and valine) 
fell 37% with insulin infusion (figure 1). 
Because of the concern that the hypoaminoacidemia 
resulting from infusion of insulin alone may prevent the 
observation of an anabolic effect on myocardial protein turnover, 
we studied a second group in which a balanced amino acid solution 
was infused during the euglycemic clamp. Our goal was to 
maintain the plasma amino acid concentrations at levels observed 
prior to the beginning of the clamp. Figure 1 demonstrates that 
the overall concentrations of the branched-chain, essential, and 
total amino acids did not significantly change from baseline 
levels. Because of the concentrations of amino acids in our 
infusion mixture (Travesol™, see methods), individual amino acid 
concentrations varied though overall there was no significant 
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Table III: Arterial Amino Acid Concentrations (uM) 
Euglvcemic Clamp Clamp ± A.A. Saline 
Basal Insulin Basal Insulin Basal Insulin 
Threonine 193±45 124±23‘ 139±14 1 23±9 154±13 146±14 
Serine 94±8 66±8t 84±10 1 08±7 97±10 90±6 
Asparagine 39±4(i> 21±2¥ 29±2 15±1¥ 31 ±2 30±3 
Glutamate 15±2 13±1 14±1 13±1 14±2 14±2 
Glutamine 386±39 265±26¥ 382±28 305±17§ 445±34 427±44 
Glycine 129±16 91±10H 91 ±6 185±7¥ 145±14 124±14 
Alanine 375±72<l> 280±36 209±16 382±14¥ 
-"fr
 
CM
 
+
i
 
o
 
CM
 1 6 9 ± 1 5 
Valine 160±14 123±16* 159 ±10 1 65±7 1 41 ±8 180±20H 
Cysteine 24±2 24±2 22±2 20±1 24±1 27±1 
Methionine 30±2e 15±2¥ 26±3e 33±2* 46±5 47±5 
Isoleucine 34±4e 10±1¥ 39±4 59±2H 54±7 86±14* 
Leucine 90±11 41±8¥ 1 01 ±9 70±3H 96±8 136±18§ 
Tyrosine 30±4 17±2¥ 25±2 13±1¥ 31 ±2 36±4 
Phenylalanine 44±3 32±2¥ 49±4 74±4¥ 50±2 59±3l 
Data represents mean values ± Standard Error of the Mean for 
arterial plasma amino acid concentrations during the basal period 
(Basal) and the last 15 minutes of either the euglycemic clamps 
(Insulin) or saline infusions (Saline). *p<0.02, tp<0.01, ¥p<0.001, 
§p<0.05, Hp<0.005, compared to basal by paired t test. (l)p<0.05 
compared to 16 hour fasted animals and ep<0.05 compared to saline 
infused animals (fasted 16 hours) by ANOVA. n=4 for threonine 
values available in each group. 
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Figure 1A: Total Amino Acid Concentrations 
INSULIN INSULIN + AA SALINE 
Arterial concentrations of total (non-basic) amino acids. Data are 
mean values ± standard error of the mean prior to experimental 
infusions (open bars) and during the last 15 minutes of the 
protocol (hatched bars). INSULIN represents the euglycemic clamp 
group, INSULIN + AA is the group which received the euglycemic 
clamp plus amino acids, and SALINE indicates the group which 
received saline infusion only. *p<0.005 compared with baseline 
state. 
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Figure IB: Branched Chain Amino Acid Concentrations 
** 
Arterial concentrations of total branched chain amino acids. Data 
are mean values ± standard error of the mean prior to 
experimental infusions (open bars) and during the last 15 minutes 
of the protocol (hatched bars). INSULIN represents the euglycemic 
clamp group, INSULIN + AA is the group which received the 
euglycemic clamp plus amino acids, and SALINE indicates the 
group which received saline infusion only. *p<0.005, **p<0.02 
compared with baseline state. 
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Figure 1C: Essential Amino Acid Concentrations 
Arterial concentrations of measured essential amino acids. Data 
are mean values ± standard error of the mean prior to 
experimental infusions (open bars) and during the last 15 minutes 
of the protocol (hatched bars). INSULIN represents the euglycemic 
clamp group, INSULIN + AA is the group which received the 
euglycemic clamp plus amino acids, and SALINE indicates the 
group which received saline infusion only. *p<0.005, **p<0.02 
compared with baseline state. 
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change in the summed amino acid concentrations. The essentia! 
amino acids methionine, isoleucine, and phenylalanine showed a 
statistically significant increase in concentration. Of other 
essential amino acids, leucine decreased and valine and threonine 
were unchanged (Table III). 
In the control group of animals receiving saline infusion 
alone that served to examine the metabolic effects of undergoing 
anesthesia and catheterization, the total amino acid concentration 
remained stable (figure 1). The concentrations of the essential 
and branched-chain amino acids, however, showed statistically 
significant increases (p<0.02 for each) over the two-hour infusion 
of saline (figure 1), as did the concentration of phenylalanine 
(Table III). 
Rates of Synthesis and Degradation by Phe Kinetics 
Insulin Infusion 
After a fast of 36 hours, the concentration of phenylalanine 
was higher in the coronary sinus of 9 of 10 animals studied (mean 
difference 1.02 ± 0.22 nmol/ml, p<0.001). There was net negative 
balance of phenylalanine during the basal period (-38 ± 9 
nmol/min, p<0.005 compared with the null hypothesis value of 0) 
which indicates that the rate of myocardial protein degradation 
exceeds the rate of synthesis. The rates of degradation and 
synthesis were estimated from the dilution of specific activity 
and extraction of labeled phenylalanine using equations 1 and 5 
respectively (see methods). In the basal state, 3H-phenylalanine 
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was significantly extracted from coronary arterial plasma (3 ± 
1%, p<0.01) and 3 H-phenylalanine specific activity was 
significantly diluted (6 ± 1%, p<0.001). When incorporated into the 
above equations, the rate of myocardial protein degradation was 
81 ±13 nmol/min, while the rate of synthesis was 38 ± 17 
nmol/min (figure 2). Following two hours of the euglycemic 
clamp, the phenylalanine balance and the rates of heart protein 
degradation and synthesis were not significantly different from 
the basal state (figure 2). 
Insulin and Amino Acid Infusion 
In overnight-fasted animals prior to insulin and amino acid 
infusion, we observed again a net negative phenylalanine balance 
(-40±6nmol/min, p<0.001 different from 0), with higher coronary 
sinus than arterial phenylalanine concentrations (mean difference 
1.12±0.15 nmol/ml). There was significant basal extraction of 
3H-phenylalanine (5±1%, p<0.001) and dilution of 3H-phenylalanine 
specific activity (7±1%, p<0.001) across the heart. This yielded 
rates of protein synthesis and degradation during the basal period 
of 79±8 nmol/min and 118±12 nmol/min respectively (figure 2). 
During the last 15 minutes of a two and one-half hour 
hyperinsulinemic euglycemic clamp with infusion of amino acids, 
the myocardial phenylalanine balance changed significantly 
(p<0.05) from negative (-40±6nmol/min) to slightly positive (6±15 
nmol/min). The synthetic rate of protein did not significantly 
change, but there was inhibition of protein degradation which fell 
50% from 118± 12 nmol/min during the basal state to 60±7 
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nmol/min during the clamp (pcO.OOl). Thus the net anabolic effect 
of insulin and amino acid infusion in these overnight-fasted dogs 
was due to inhibition of protein degradation, rather than 
stimulation of protein synthesis. 
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Figure 2A: Cumulative Rates of Synthesis. Degradation. 
and Balance (Group I) 
SYNTHESIS 
A 
DEGRADATION 
BALANCE 
Rates of myocardial protein synthesis, degradation, and 
phenylalanine balance prior to experimental infusions (left group 
of bars) and during the last 15 minutes (right group of bars) of 
intervention. Figure 1A is the euglycemic clamp group. Data are 
mean values ± standard error of the mean. 
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Figure 2B: Cumulative Rates of Synthesis. Degradation. 
and Balance (Group II) 
I_| SYNTHESIS 
DEGRADATION 
FI BALANCE 
V_ J 
Rates of myocardial protein synthesis, degradation, and 
phenylalanine balance prior to experimental infusions (left group 
of bars) and during the last 15 minutes (right group of bars) of 
intervention. Figure 2B represents animals which received the 
euglycemic clamp with amino acid infusion. Data are mean values 
± standard error of the mean. *p<0.05, **p<0.005 compared with 
pre-infusion values. 
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Figure 2C: Cumulative Rates of Synthesis. Degradation. 
and Balance (Group III) 
SYNTHESIS 
1 % \ DEGRADATION 
I BALANCE 
v _J 
Rates of myocardial protein synthesis, degradation, and 
phenylalanine balance prior to experimental infusions (left group 
of bars) and during the last 15 minutes (right group of bars) of 
intervention. Figure 2C represents animals which received saline 
infusion alone. Data are mean values ± standard error of the mean. 
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Saline Infusion 
Following an overnight fast, the animals in the saline 
control group also had a net negative arterial-coronary sinus 
phenylalanine concentration difference (-1.72±0.36 nmol/ml, 
p<0.005), and a negative phenylalanine balance (-68±19 nmol/min, 
p<0.01 compared to 0). Following two hours of saline infusion, 
phenylalanine balance remained negative (-60±17 nmol/min); a 
finding significantly different from the neutral balance achieved 
in animals receiving insulin and amino acid infusion (p<0.01). 
Myocardial protein synthetic rate did not change significantly 
during the experiment and was similar to the synthetic rates in 
the other experimental groups. The rate of heart protein 
degradation at the end of saline infusion (101 ±18 nmol/min) 
significantly exceeded that seen in overnight-fasted animals 
receiving insulin and amino acid infusion (60±7 nmol/min, p<0.05) 
(figure 2). 
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Discussion 
Employing a novel method of measuring protein synthesis 
and degradation, we have provided the first evidence that 
physiologic hyperinsulinemia and circulating amino acids may 
have an important role in determining cardiac protein metabolism 
in vivo. Measurement of the balance of phenylalanine across the 
heart provides an overall assessment of net protein kinetics. 
Without the necessity of direct tissue biopsy for biochemical 
analysis, the isotope dilution method also permits the first 
analysis of the effects of experimental interventions within the 
same animal. Furthermore, with this technique one has the ability 
to measure simultaneously rates of synthesis and degradation and 
to monitor minute to minute the changes in heart protein 
metabolism with changing experimental conditions. While other 
investigators have determined rates of protein degradation by 
calculating the difference between rates of synthesis determined 
by isotope incorporation and change in heart mass over time 
(reviewed in Barrett, 1989), we rely on direct measurements of 
the dilution of tracer phenylalanine to provide an independent 
measure of degradation. 
Though the isotope dilution method overcomes many of the 
limitations inherent in previously employed techniques to study 
cardiac protein synthesis, several theoretical constraints pertain 
in interpreting results from the current study. We assume, though 
do not prove, that the tritium-labeled phenylalanine employed as a 
tracer molecule is handled identically to the native amino acid. 
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Furthermore, we assume that the size and specific activity of the 
intracellular free phenylalanine pool is not changing during the 
measurement period. There is no evidence that an isotope effect 
exists for tritium-labeled phenylalanine or that phenylalanine is 
concentrated in a cellular store, so with the constant plasma 
levels maintained in our protocol it is unlikely that a significant 
gradient exists. The major uncertainty in the current method is 
the assumption that venous phenylalanine specific activity we 
measure closely approximates the specific activity of 
phenlylalanyl-tRNA in cardiac muscle cells. As protein is 
degraded inside cells, unlabeled phenylalanine is released to mix 
with the labeled molecule, lowering specific activity relative to 
that in arterial blood. Though in previous investigation in this 
laboratory in rat hearts phenylalanine has been shown to 
equilibrate rapidly among the tRNA, free cellular, and venous 
plasma pools (Revkin, 1990), we cannot exclude a significant 
species difference at work in the dogs. It is technically 
impractical, unfortunately, to quantify the tRNA specific activity 
in large animals because of the enormous quantity of radioactive 
tracer molecule it would require for valid measurements. 
To study accurately the kinetics of protein turnover in the 
heart, it was necessary to refine the isotope dilution technique as 
originally described (Barrett, 1987). Because of the heart’s 
significantly greater oxygen requirement, the rate of blood flow 
per gram of tissue is 30-fold higher in cardiac than in skeletal 
muscle (Liang, 1982). Assuming comparable rates of protein 
turnover, the much greater flow means that a much lower 
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fractional extraction of amino acid is necessary to provide for 
protein synthesis and the dilution of specific activity from 
protein degradation is also substantially less. This explains the 
significantly narrower arteriovenous differences in phenylalanine 
radioactivity and specific activity seen across the heart than 
across skeletal muscle in previous studies from this laboratory 
(Revkin, 1990; Barrett, 1987; Gelfand, 1987). With the 
introduction of phenylalanine analysis by HPLC in the current 
experiment, the new precision in our measurements of amino acid 
balance (1.8% coefficient of variation vs. 5-7% with previous 
method) allowed us to investigate cardiac protein metabolism 
having minimized the systematic error in this measurement. In 
the experimental group which received amino acid 
supplementation, total phenylalanine increased 50% from baseline. 
This resulted in even smaller fractional dilution of specific 
activity, but the precision of this refined technique permitted us 
to obtain reproducible measurements even in this experimental 
group. 
We studied the effects of physiologic interventions on three 
groups of fasted dogs. We measured the rates of protein synthesis 
and degradation in animals fasted 36 hours before and after a 
two-hour hyperinsulinemic euglycemic clamp. A second group, 
fasted overnight, received the insulin clamp and an infusion of an 
amino acid solution for two and one-half hours. We studied a third 
group, also fasted overnight, before and after a two-hour infusion 
of saline. Though in our experiments, each animal is an 
independent study which serves as its own control, the saline 
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group served as another control to disclose any unforeseen 
metabolic effects of the anesthesia and immobilization inherent 
in our experimental design. 
We report five important findings from the study of these 
three experimental groups. First, after a brief overnight or 36- 
hour fast, the heart is in a net catabolic state as indicated by 
negative protein balance. Second, the degradative rates in 36- 
hour fasted animals are significantly lower than those fasted 
overnight. Third, insulin has no discernable effect on the rate of 
protein synthesis in these fasted animals in combination with 
glucose alone or glucose and amino acids. Fourth, physiologic 
concentrations of insulin inhibit this net catabolism by stopping 
proteolysis. Finally, the anti-proteolytic effect of insulin is 
inhibited by the systemic hypoaminoacidemia induced by insulin 
infusion. 
Although contrary to the intuitive impression that cardiac 
muscle would be preserved during fasting, our finding that the 
canine heart is in a net catabolic state even after a brief fast is 
consistent with older studies in small animals and parallels more 
recent data in large animals and man. In rats, starvation results 
in a net loss of protein in both the whole body and heart (Preedy, 
1984), though there is some evidence that the heart undergoes a 
slower net degradation than other muscles (reviewed in Sugden, 
1991). We did not measure skeletal muscle kinetics in this study, 
but a previous investigation using the same isotope dilution 
method in dogs has demonstrated that it is also in a net catabolic 
state after an overnight fast (Barrett, 1987). Separate studies 
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performed by this laboratory have also demonstrated that both 
cardiac and skeletal muscle are in negative phenylalanine balance 
in the post-absorptive state in man (Young, 1991; Gelfand, 1987). 
We found that the rate of myocardial protein degradation 
was lower in animals fasted 36 hours than in those fasted 
overnight (81±13 vs 121 ±12 nmol/min, p<0.05). Previous studies 
have demonstrated that in both the rat (Preedy, 1984) and rabbit 
(Samarel, 1987), fasting inhibits protein synthesis. By assessing 
protein degradation indirectly by taking the difference between 
changes in heart mass and measured rates of protein synthesis, 
Samarel reported fasting had no significant effect on the rate of 
degradation. Our study which estimates protein degradation 
directly and independently suggests that cardiac protein loss may 
decline as the fasting period increases. 
In the present investigations, the rates of protein synthesis 
were unchanged by hyperinsulinemia in any of the experimental 
groups. This contrasts with earlier findings both in vitro and in 
vivo. In isolated, perfused hearts, where addition of insulin to 
perfusate stimulates protein synthesis (Rannels, 1975; Flaim, 
1983, Preedy, 1984). Application of these findings to humans or 
large animals is complicated, however, by the artificial and highly 
catabolic nature of the isolated, perfused rat heart and the 
generally superphysiologic concentrations of insulin used in these 
experiments. In young, growing rats with streptozotocin-induced 
diabetes, insulin increases the rate of protein synthesis (Pain, 
1974; Ashford, 1986). Interpretation of these observations is 
difficult in the diabetic animal with its complex array of 
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compensatory endocrinologic mechanisms operating (reviewed in 
Sugden, 1991). Furthermore, insulin served only to restore the 
rate of protein synthesis to that seen in fasted controls; it did not 
stimulate synthesis to that seen in normal rats fed ad libitum. 
Recent data from this lab in older rats demonstrates that insulin 
alone does not increase cardiac protein synthesis (McNulty, 1989). 
These findings do not preclude the possibility that there is some 
physiologic significance to the low, but measurable levels of 
circulating insulin in the basal state in this study or in any normal 
post-absorptive animal. Insulin at these low levels may serve as 
a permissive hormone, priming cells to receive stimulatory 
signals from other circulating molecules. 
Our finding that insulin infusion, when coupled with 
maintenance of basal concentrations of amino acids, inhibits 
proteolysis is consistent with previous studies in the rat heart 
and other investigations of the metabolic influence of insulin. 
Because of the greater methodologic difficulties inherent in 
quantifying protein degradative rates (see introduction), few 
careful studies have addressed this issue in the heart. In isolated, 
perfused hearts, insulin at high concentrations has been shown to 
decrease protein breakdown (Rannels, 1975; Curfman, 1980). 
Ribosomal protein degradation was shown to be particularly 
sensitive to inhibition by insulin in vivo in diabetic rats (Ashford, 
1986). Again, the pertinence to humans or large animals of 
findings in these complicated systems is difficult to assess. Our 
results are quite consistent with recent studies in human forearm 
skeletal muscle (Gelfand, 1987) and in whole body in man 
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(Fukagawa, 1985; Tessari, 1986). Numerous discrete mechanisms 
of protein breakdown have been described (reviewed in Kettelhut, 
1988). Insulin appears to block protein degradation by inhibiting 
autophagy by lysosomes (Rannels, 1975). 
That there was no effect of insulin in the group fasted 36 
hours and not repleted with amino acids may be explained by 
insulin resistance or by hypoaminoacidemia. Though the animals 
had been fasted for 36 hours, there is no evidence that they had 
become resistant to insulin. Myocardial glucose utilization 
increased dramatically in response to insulin and whole body 
glucose disposal was similar to the groups fasted only overnight 
(Table I). Furthermore, studies in human forearm skeletal muscle 
demonstrate that even after a 60-hour fast when muscle is 
markedly resistant to insulin-mediated glucose disposal, it 
remains sensitive to insulin's anti-proteolytic effects (Fryburg, 
1990). 
The generalized hypoaminoacidemia resulting from insulin 
infusion in the 36-hour fasted animals probably explains the lack 
of effect on proteolysis. In man, insulin also decreases plasma 
concentrations of amino acids (Fukagawa, 1986). The 
complementary role of insulin and amino acids as circulating 
regulators has been demonstrated in studies of whole body protein 
metabolism in man (Fukagawa, 1989). Volunteers undergoing the 
hyperinsulinemic euglycemic clamp without amino acid 
supplementation had little change in whole body proteolysis. 
When amino acid levels were maintained near basal levels, 
however, insulin's anti-proteolytic effects were manifest 
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(Flakoll, 1989). Another study has implicated the branched-chain 
amino acids (which drop dramatically during insulin infusion) as 
responsible for determining the organisms sensitivity to insulin's 
regulation of proteolysis (Frexes-Steed, 1990). 
We attempted to maintain plasma amino acids near basal 
levels during insulin infusion by administering a balanced amino 
acid solution. Although changes in individual amino acids did 
occur (alanine and glycine increased and leucine fell significantly 
from basal levels), we were successful overall in maintaining the 
concentrations of essential, branched chain, and total measured 
amino acids (Table III and figure 2). In studies of forearm 
skeletal muscle in vivo, it is possible to infuse insulin locally and 
study the effects of insulin without changing systemic amino acid 
levels (Gelfand, 1987), but this is technically impractical in 
studying cardiac metabolism. Glutamine and leucine have been 
implicated as regulators of muscle protein synthesis, but have 
their stimulatory effect at much higher concentrations than those 
achieved in our study (reviewed in Sugden, 1991). Though in our 
design we cannot formally exclude the possibility that one or 
more of the amino acids alone is responsible for the effect 
observed, our results are compatible with those observed in 
similar experiments in whole body protein metabolism in which 
plasma leucine concentrations are maintained at basal levels 
(Flakoll, 1989). Furthermore, in our overnight-fasted groups, 
glutamine and leucine levels changed significantly from basal, but 
did not consistently correlate with changes in measured synthetic 
or degradative rates (Table III and figure 1). The statistically 
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significant rise in phenylalanine concentration with infusion of 
amino acids 
The only significant change in hemodynamic parameters 
observed was a 10% increase in blood pressure during the course 
of the two and one-half hour infusion of insulin and amino acids 
(Table II). This increase may be explicable by the amino acid 
infusion or by variability in our delivery of anesthesia during this 
longer experiment. Insulin in superphysiologic doses may activate 
the sympathetic nervous system independent of hypoglycemia; in 
the physiologic doses administered in our study, however, this 
phenomenon generally does not occur (Liang, 1982). Though it is 
possible that this increase in demand on the heart contributed to 
the observed decrease in proteolysis, several factors argue 
against this being significant. First, other parameters which tend 
to parallel myocardial work, e.g. the calculated cardiac double 
product or coronary blood flow, were unchanged throughout the 
experiment. Second, studies of the influence of increased demand 
on myocardial protein kinetics, which measure the effects of 
doubling systolic pressures, show that this change results 
primarily in increased protein synthesis (Gordon,1986), and has no 
effect on the rate of protein degradation (Smith, 1983). In our 
study we observed a considerably more modest change in systemic 
resistance. 
In summary, we have observed that insulin has a significant 
influence on protein kinetics in the canine heart. In many large 
animals, nutrients are consumed in large quantities several times 
per day. The consumption of a big meal may be associated with a 

significant secretion of insulin which lasts for two to three 
hours. Between meals, insulin levels fall and bodily stores of 
carbohydrates and amino acids must provide the chemical 
substrates for diverse biochemical processes. In an experimental 
system which closely approximates this true physiology of large 
animals, we have demonstrated that insulin inhibits the 
catabolism of heart protein found after a brief period of fasting. 
This finding may be relevant in many situations in which patients 
undergo prolonged periods of inadequate nutrition or their hearts 
suffer some injury; both scenarios which are found in hospitals 
every day. Furthermore, this may help explain why people with 
hypertension and high circulating levels of insulin (because they 
are resistant to the effects of insulin on glucose disposal) are 
often found to have remarkably enlarged hearts. With an 
understanding of the physiology of these processes, it may be 
possible to devise ways to improve the care of these patients. 
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